Key comorbidities in the development of post-COVID conditions: diabetes mellitus, hypertension, and obesity
Open Access
- 1 January 2026
- journal article
- Published by FapUNIFESP (SciELO) in Revista da Escola de Enfermagem da USP
- Vol. 60
Abstract
Objective: To analyze and compare the symptoms of post-COVID condition (PCC) in patients with and without chronic comorbidities, such as diabetes, hypertension, and obesity. Method: This is a cross-sectional and analytical study, considering a sample of 350 patients with PCC treated in Primary Health Care services. Data were collected from medical records and analyzed using a Poisson regression model to estimate the prevalence ratio. Results: The prevalence of PCC symptoms was reduced by 50% for headache and by 64% for sore throat in non-diabetic individuals. People with hypertension showed twice the prevalence of muscle weakness and/or loss of strength compared to those with normal blood pressure. In addition, diarrhea and upper limbs tingling/throbbing were more prevalent in obese individuals. Conclusion: The study presented a bidirectional relationship between PCC and pre-existing chronic conditions, providing a detailed understanding of how specific comorbidities influence PCC symptoms.Keywords
This publication has 25 references indexed in Scilit:
- The effect of pre-COVID and post-COVID vaccination on long COVID: A systematic review and meta-analysisJournal of Infection, 2024
- The prevalence of long COVID in people with diabetes mellitus–evidence from a UK cohorteClinicalMedicine, 2024
- Vaccination after developing long COVID: Impact on clinical presentation, viral persistence, and immune responsesInternational Journal of Infectious Diseases, 2023
- Outpatient treatment of COVID-19 and incidence of post-COVID-19 condition over 10 months (COVID-OUT): a multicentre, randomised, quadruple-blind, parallel-group, phase 3 trialThe Lancet Infectious Diseases, 2023
- The bidirectional association between diabetes and long-COVID-19 – A systematic reviewDiabetes Research and Clinical Practice, 2022
- Long-Term Cardiovascular Effects of COVID-19: Emerging Data Relevant to the Cardiovascular ClinicianCurrent Atherosclerosis Reports, 2022
- Long COVID: systemic inflammation and obesity as therapeutic targetsThe Lancet Respiratory Medicine, 2022
- Muscle dysfunction in the long coronavirus disease 2019 syndrome: Pathogenesis and clinical approachReviews in Medical Virology, 2022
- Risks and burdens of incident diabetes in long COVID: a cohort studyThe Lancet Diabetes & Endocrinology, 2022
- Long COVID: An overviewDiabetes & Metabolic Syndrome: Clinical Research & Reviews, 2021